Our mission is to transform wastewater infrastructure into public health observatories. Named as one of Fast Company’s most innovative companies in the world in 2021, Biobot Analytics is a wastewater epidemiology company and uses technology developed at MIT to measure biomarkers in sewage to better understand population health in cities.
Biobot Analytics is a Y Combinator company in the Winter 2018 batch. Its directory entry describes it as: Population health analytics powered by wastewater. The founders listed are Newsha Ghaeli (Founder/President), Mariana Matus (Founder) (Y Combinator directory entry, November 2, 2017).
Sell to companies like Biobot Analytics? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2017-11-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Biobot Analytics.
Free to see. No signup.
More on Biobot Analytics and the records around it.
Get an email when Biobot Analytics changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Biobot Analytics raises, hires or launches. No email unless you switch it on.
Watch Biobot Analytics →Get the full cited report on Biobot Analytics
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biobot Analytics: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Our mission is to transform wastewater infrastructure into public health observatories. Named as one of Fast Company’s most innovative companies in the world in 2021, Biobot Analytics is a wastewater epidemiology company and uses technology developed at MIT to measure biomarkers in sewage to better understand population health in cities. We first launched an opioid product to support government and public health officials in responding to the opioid epidemic, and in 2020 launched a Covid19 product to estimate the scope and trend of the outbreak in communities. We have operated in almost 500 communities across 43 U.S. states, generating Covid19 case estimates for over 13% of the U.S. population. Battling the opioid epidemic and now the Covid19 pandemic is just the beginning - we’re transforming sewage into a data asset and building a public health database. Eventually, Biobot data will be an early warning system for disease outbreaks, a map of nutrition disparities, and more. Please visit our website at www.biobot.io
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biobot Analytics: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biobot Analytics covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Biobot AnalyticsYou get an alert in MentionFox the next time this company shows up.
If you're behind Biobot Analytics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for Biobot Analytics. With no account yet, you sign up free and land on the result.
Data and analytics startups Healthcare and health tech startups
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-biobot-analytics